PSCI

The pharmaceutical industry continues to evolve with an increasing focus on responsible sourcing, sustainability, and collaboration across the supply chain. Under a new model to recognise suppliers within the pharmaceutical and healthcare industry that share its vision of building responsible supply chains, the Pharmaceutical Supply Chain Initiative (PSCI) has welcomed its first cohort of Supplier Partners: Delpharm, Samsung Biologics, and Suven. 
 

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain. This can only be achieved through industry-wide collaboration that sets the standard for what a responsible supply chain looks like and provides support to suppliers to achieve these goals. The Pharmaceutical Supply Chain Initiative (PSCI) and our membership of 60+ pharma and healthcare companies are leading this collaboration to create harmonized approaches and standards for our value chains. Through our Principles for Responsible Supply Chain Management, shared audit program, and supplier maturity model, our members are putting ESG and sustainability into practice to create responsible supply chains.